APPLICATION
ANDA070450
TYPE
ANDA
ORIGINAL APPROVAL
1985-11-22
LATEST ACTION
2005-08-04
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
FUROSEMIDEDiscontinued
FUROSEMIDE 40MG · TABLET · ORAL
Approval history
2005-08-04Labeling · Supplement 26AP
2002-11-07Manufacturing (CMC) · Supplement 25AP
2001-08-31Manufacturing (CMC) · Supplement 24AP
1999-11-10Manufacturing (CMC) · Supplement 23AP
1999-06-23Manufacturing (CMC) · Supplement 21AP
1998-12-11Labeling · Supplement 22AP
1998-12-01Manufacturing (CMC) · Supplement 20AP
1996-04-29Labeling · Supplement 19AP
1993-06-11Labeling · Supplement 18AP
1993-04-08Labeling · Supplement 17AP
1992-08-24Labeling · Supplement 16AP
1992-06-02Labeling · Supplement 15AP
1991-01-10Manufacturing (CMC) · Supplement 11AP
1990-12-04Labeling · Supplement 14AP
1990-08-02Labeling · Supplement 13AP
1990-06-04Labeling · Supplement 12AP
1990-05-08Manufacturing (CMC) · Supplement 10AP
1988-11-04Manufacturing (CMC) · Supplement 9AP
1988-06-30Manufacturing (CMC) · Supplement 8AP
1988-06-20Manufacturing (CMC) · Supplement 7AP
1987-06-24Manufacturing (CMC) · Supplement 5AP
1986-10-30Manufacturing (CMC) · Supplement 1AP
1985-11-22OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.